Application of bacillus coagulans JA845 in preparation of health care product or food for assisting in lowering blood pressure
Health products or foods prepared using Bacillus coagulans JA845 utilize their antioxidant properties to fill the technological gap in adjunctive treatment of hypertension, achieving safe and effective blood pressure reduction and improving arterial health.
Patent Information
- Application Number
- CN202610074903.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-20
- Publication Date
- 2026-05-12
AI Technical Summary
There is no existing technology regarding the use of Bacillus coagulans, which has unique antioxidant activity, as an adjunct treatment for hypertension, and there is a lack of safe and effective means of lowering blood pressure.
Using Bacillus coagulans JA845 as a probiotic, health products or foods that help lower blood pressure are prepared. By utilizing its antioxidant effects, it regulates the intestinal flora, inhibits angiotensin-converting enzyme activity, reduces systolic blood pressure, improves arterial vascular pathological characteristics, reduces the secretion of adhesion factors, inhibits inflammatory responses and angiotensin secretion, and enhances antioxidant capacity.
It significantly reduces systolic blood pressure in hypertensive model rats, improves arterial vascular pathology, reduces the levels of adhesion factors and inflammatory factors, inhibits angiotensin secretion, and enhances antioxidant capacity, achieving a safe and effective blood pressure-lowering effect.